Ribometrix, Inc.

Roche Holding AG , Genentech, Inc. and their affiliated companies were the busiest deal makers in the biopharmaceutical sector for the second consecutive year in 2021, with 23 deals across all cate

As venture capital financings for biopharmaceutical companies continues to head into record-breaking territory again in 2021, Illumina Ventures and Jeito Capital announced two new venture capital fund

Roche Holding AG / Genentech, Inc. global oncology partnering head Don O’Sullivan is eager to get back to the days of discussing deals in person over a glass of wine, but noted in an interview that t

Who: Roche/Ribometrix What: Roche’s Genentech subsidiary and Ribometrix will team up to discover and develop small molecule drug candidates that can modify RNA. Why: This is Roche/Genentech’s thi